Peter G. Traber

Companies

• Selecta Biosciences (United States)Chief Medical Officer Aug 4, 2020 to Sep 26, 2023¹
• Caladrius BiosciencesBoard member Jan 22, 2015 to Jan 12, 2022²
• GALECTIN THERAPEUTICS INCChief executive officer May 31, 2011 to Jun 15, 2018³
• GALECTIN THERAPEUTICS INCPresident May 31, 2011 to Jun 15, 2018³
• GALECTIN THERAPEUTICS INCBoard member Feb 20, 2009 to Dec 6, 2016⁴

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• SBSelecta Biosciences (United States) RNAC451,826 shares⁵$2.7M at $6.08Sep 25, 2023
• CBCaladrius Biosciences LSTA149,190 shares⁶$146.2K at $0.98Jan 10, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

• Sep 25, 2023Sold 705 shares at $1.06 of Selecta Biosciences (United States)⁵
• Jan 5, 2023Sold 20 shares at $1.11 of Selecta Biosciences (United States)⁷
• Jan 5, 2023Sold 3,445 shares at $1.13 of Selecta Biosciences (United States)⁷
• Jan 4, 2023Sold 15 shares at $1.14 of Selecta Biosciences (United States)⁷
• Jan 4, 2023Sold 8,164 shares at $1.13 of Selecta Biosciences (United States)⁷
• Jan 2, 2023Granted 200,000 shares of Selecta Biosciences (United States)⁸
• Jan 10, 2022Granted 65,430 shares of Caladrius Biosciences⁶
• Jan 5, 2022Sold 3,226 shares at $3.09 of Selecta Biosciences (United States)⁹
• Jan 3, 2022Granted 90,200 shares of Selecta Biosciences (United States)¹⁰
• Dec 10, 2021Sold 4,083 shares at $2.99 of Selecta Biosciences (United States)¹¹
• Dec 8, 2021Granted 13,750 shares of Selecta Biosciences (United States)¹²
• Oct 13, 2021Sold 3,636 shares at $4.39 of Selecta Biosciences (United States)¹³
• Oct 1, 2021Granted 13,750 shares of Selecta Biosciences (United States)¹⁴